Transfer pricing requires evidence for AMP transactions, functionally reliable comparables, and appropriate aggregation or Berry Ratio benchmarking me...
Revisionary jurisdiction cannot reopen share capital assessments where adequate inquiry supports a permissible view and no independent error is establ...
Reassessment jurisdiction fails where unverified portal information is aggregated without examining the taxpayer's explanation or relevance of entries...
Statutory sanction for delayed reassessment requires approval from the prescribed authority; approval by an inferior authority invalidates jurisdictio...
Transfer pricing margin adjustments require matching treatment of non-operating income and related costs, with comparability issues reconsidered on ev...
Preliminary-expense amortisation and MAT exempt-income adjustments prevailed, while trademark costs and managerial remuneration require fresh verifica...
Export valuation requires contemporaneous evidence; unrelated invoices cannot prove overvaluation, and dual penalties on firm and partner are impermis...
Weighted deduction for scientific research expenditure was allowed on regular remuneration paid to the Chief Scientific Officer, as it was incurred for day-to-day research services, but the one-time performance bonus linked to patent licensing success was excluded as not directly related to research activity. ESOP expenditure disallowance was deleted by following the Tribunal's earlier orders in the assessee's own case. Weighted deduction under section 35(2AB) was confined to expenditure verified and certified by DSIR in Form 3CL, so the balance manpower and travel claim was not extended the deduction. For the alternative claim, deduction under section 37(1) was permitted subject to verification that the same amount had not already been claimed in the profit and loss account.
Weighted deduction for scientific research expenditure was allowed on regular remuneration paid to the Chief Scientific Officer, as it was incurred for day-to-day research services, but the one-time performance bonus linked to patent licensing success was excluded as not directly related to research activity. ESOP expenditure disallowance was deleted by following the Tribunal's earlier orders in the assessee's own case. Weighted deduction under section 35(2AB) was confined to expenditure verified and certified by DSIR in Form 3CL, so the balance manpower and travel claim was not extended the deduction. For the alternative claim, deduction under section 37(1) was permitted subject to verification that the same amount had not already been claimed in the profit and loss account.
Note: It is a system-generated summary and is for quick reference only.